Extended Field Radiation Therapy Versus Delayed Hormonal Therapy in Node Positive Prostatic Adenocarcinoma
Authors:
- David F. PaulsonDPDavid F. Paulson
- Wayne A. ClineWCWayne A. Cline
- R. Bruce KoefootRKR. Bruce Koefoot
- Wanda HinshawWHWanda Hinshaw
- Stephen StephaniSSStephen Stephani
- 1 May 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 127 (5) , 935-937
Abstract
This study was undertaken to determine the disease control and survival advantage of either extended field megavoltage irradiation or delayed androgen ablation in a randomized clinical trial. Comparison of the 2 treatments, using either time-to-first evidence of treatment failure or survival, demonstrates an advantage to extended field radiation.Keywords
This publication has 5 references indexed in Scilit:
- Prognosis of Patients With Stage D1 Prostatic AdenocarcinomaJournal of Urology, 1981
- Prostatic Adenocarcinoma: Relationship of Grade and Local Extent to the Pattern of MetastasesJournal of Urology, 1977
- Implantation of 125I in Prostatic CancerSurgical Clinics of North America, 1974
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958